share_log

中國中藥：截至二零二四年四月三十日止月份之股份發行人的證券變動月報表

TRAD CHI MED: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024

Hong Kong Stock Exchange ·  May 7 16:39
Summary by Futu AI
中國中藥控股有限公司（股份代號00570）於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年4月30日的情況。報表顯示，該公司在過去一個月內並無股份資本變動，包括普通股股份、股份期權、權證、可換股票據以及其他任何與發行股份相關的協議或安排。此外，報表中亦未提及有關香港預託證券的資料。公司聯席公司秘書趙東吉確認，所有證券的發行均已獲得董事會的正式授權，並且符合香港證券上市規則的所有相關要求。
中國中藥控股有限公司（股份代號00570）於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年4月30日的情況。報表顯示，該公司在過去一個月內並無股份資本變動，包括普通股股份、股份期權、權證、可換股票據以及其他任何與發行股份相關的協議或安排。此外，報表中亦未提及有關香港預託證券的資料。公司聯席公司秘書趙東吉確認，所有證券的發行均已獲得董事會的正式授權，並且符合香港證券上市規則的所有相關要求。
China Pharmaceutical Holdings Limited (stock code 00570) filed with Hong Kong Trading and Settlement Limited on 7 May 2024 with Hong Kong Trading and Settlement Holdings Limited, covering the situation as of 30 April 2024. The report showed that the company had no change in share capital over the past month, including common shares, stock options, warrants, convertible notes and any other agreements or arrangements related to the issue of shares. In addition, the report did not mention information on Hong Kong pre-trust securities. The Company's Joint Secretary, Zhao Tongji, confirmed that all securities have been formally authorized by the Board of Directors and comply with all relevant requirements of the Hong Kong Securities Listing Rules.
China Pharmaceutical Holdings Limited (stock code 00570) filed with Hong Kong Trading and Settlement Limited on 7 May 2024 with Hong Kong Trading and Settlement Holdings Limited, covering the situation as of 30 April 2024. The report showed that the company had no change in share capital over the past month, including common shares, stock options, warrants, convertible notes and any other agreements or arrangements related to the issue of shares. In addition, the report did not mention information on Hong Kong pre-trust securities. The Company's Joint Secretary, Zhao Tongji, confirmed that all securities have been formally authorized by the Board of Directors and comply with all relevant requirements of the Hong Kong Securities Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.